Home > Hepatitis and drug use.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2011) Hepatitis and drug use.

URL: http://www.emcdda.europa.eu/themes/hepatitis

EMCDDA thematic page on hepatitis and drug use.

In Europe, injecting drug use is a major transmission route for hepatitis C virus (HCV) infections. Estimates suggest that around 1 million people who have injected drugs may be living with HCV in the EU today. Typically between 40 % and 90 % of injecting drug users are infected, and many contract the disease soon after their first injection. This is due to unsafe injecting practices which include sharing of needles/syringes and other injection materials. The high prevalence of HCV infection among drug injectors represents a serious public health problem for the EU, made worse by the fact that many of those who have contracted the virus are unaware of their infection status. HCV infection may lead to severe chronic liver disease and premature death. This can occur after many years of asymptomatic infection.


Item Type:Evidence resource
Publication Type:Other
Drug Type:Alcohol or other drugs in general
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:2011
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
T Demographic characteristics > Intravenous / injecting drug user
G Health and disease > Disorder by cause > Communicable disease > Hepatitis B
G Health and disease > Disorder by cause > Communicable disease > Hepatitis A
G Health and disease > Disorder by cause > Communicable disease > Viral hepatitis
VA Geographic area > Europe
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction

Repository Staff Only: item control page